Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-05-17
2011-05-17
Pak, Michael (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07943579
ABSTRACT:
Implant articles with improved osseointegrating properties, osteogenic implant materials, and process of inducing differentiation of mesenchymal stem cells, proliferation of osteoblast and attachment of cells to implant surface, comprising the step of impregnating the surface with a solution containing osteoactive bone sialoprotein, recombinant human bone sialoprotein, recombinant His-Myc-Ek-BSP or substantive fragments thereof that have not been in contact with serum containing complement factor H or any other BSP processing material.
REFERENCES:
patent: 6458763 (2002-10-01), Peterson et al.
patent: 2004/0109937 (2004-06-01), Jennissen et al.
patent: 2005/0064007 (2005-03-01), Steinemann et al.
patent: 2005/0107887 (2005-05-01), Knothe Tate et al.
patent: 1 084 719 (2001-03-01), None
patent: WO 94/13310 (1994-06-01), None
patent: WO 99/08730 (1999-02-01), None
patent: WO 99/16792 (1999-04-01), None
patent: WO 02/085250 (2002-10-01), None
Immundiagnostik AG
Lydon James C.
Pak Michael
LandOfFree
Osteogenic implant matrices and endosseous tooth implants... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Osteogenic implant matrices and endosseous tooth implants..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteogenic implant matrices and endosseous tooth implants... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2679465